JPMorgan Global Alternatives has made three lettings, to global life science businesses Biogen, Leo Laboratories and LabCorp Clinical Development, at Foundation Park in Maidenhead.
The new occupiers have all signed 10-year lease commitments, for a combined 56,000 square feet at the recently constructed Building 5.
Foundation Park is owned by a fund advised by JPMorgan Global Alternatives. The park secured Ultra Electronics, another “intelligent industries” business, on a 56,000 square foot prelet for Building 1, for a 20-year term in January 2022.
Paul Harris, head of UK real estate asset management at JPMorgan Asset Management, said: “We are delighted that three global life science businesses have chosen to relocate to Foundation Park, further enhancing its reputation as the dominant office and life science location in the Thames Valley. Given current leasing momentum and the Park’s diverse tenant mix, we are likely to commence 45,000 sq of speculative development with the fully lab enabled Building 2.”
Bray Fox Smith and Cushman & Wakefield represented JPMorgan.